TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31361516

Group type: EXPERIMENTAL
Intervention: Keep It Up! (KIU!) online intervention
Number of subjects: 0
Study: 28434547

Group type: EXPERIMENTAL
Intervention: Stress-dose corticosteroid (SDC) regimen: 2 mg/kg methylprednisolone perioperatively, followed by hydrocortisone infusion (0.2 mg/kg/h) for 5 days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Stress-dose corticosteroid (SDC) regimen
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 25585082

Group type: EXPERIMENTAL
Intervention: Combined topical diltiazem ointment (for 6 weeks) and botulinum toxin A injection (once)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Partial lateral internal sphincterotomy
Number of subjects: 99
Study: 23507282

Group type: EXPERIMENTAL
Intervention: 800 mg solithromycin orally on day 1, followed by 400 mg orally daily on days 2 to 5
Number of subjects: 132

Group type: COMPARATOR
Intervention: 750 mg levofloxacin orally daily on days 1 to 5
Number of subjects: 132

Group type: COMPARATOR
Intervention: levofloxacin
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: solithromycin
Number of subjects: 132
Study: 21669583

Group type: EXPERIMENTAL
Intervention: Vegetables before carbohydrate (VBC)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Exchange-based meal plan (EXB)
Number of subjects: 101
Study: 19452377

Group type: COMPARATOR
Intervention: SSRIs (citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline)
Number of subjects: 0

Group type: COMPARATOR
Intervention: SNRI (venlafaxine)
Number of subjects: 0
Study: 17164458

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 16958
Study: 15120545

Group type: EXPERIMENTAL
Intervention: Auditory repetition priming
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Word stem completion priming
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lexical decision priming measures
Number of subjects: 0
Study: 11146900

Group type: EXPERIMENTAL
Intervention: Propinox 10 mg
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Propinox 20 mg
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Propinox 30 mg
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 9442224

Group type: EXPERIMENTAL
Intervention: MRM (Magnetic Resonance Myelography)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional Myelography
Number of subjects: 41
Study: 8103133

Group type: EXPERIMENTAL
Intervention: Blood cardioplegia with warm reperfusion (30 patients)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intermittent aortic crossclamping (30 patients)
Number of subjects: 60
Study: 3518408

Group type: EXPERIMENTAL
Intervention: 5-Aminosalicylic acid (5-ASA) enema (4-g nightly retention)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Hydrocortisone enema (control group)
Number of subjects: 18
Study: 30242335

Group type: EXPERIMENTAL
Intervention: Canakinumab (50 mg, 150 mg, or 300 mg) administered subcutaneously every 3 months
Number of subjects: 10059

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10059
Study: 27310033

Group type: COMPARATOR
Intervention: Control group of a brief cessation intervention
Number of subjects: 190
Study: 23418746

Group type: EXPERIMENTAL
Intervention: 1-piece (STM) dental implant system
Number of subjects: 60

Group type: COMPARATOR
Intervention: 2-piece (BRA) dental implant system
Number of subjects: 60
Study: 22592097

Group type: EXPERIMENTAL
Intervention: Fosamprenavir (FPV) with or without ritonavir (100 mg or 200 mg)
Number of subjects: 1319
Study: 21058244

Group type: EXPERIMENTAL
Intervention: Preoperative playroom (case group)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (standard preoperative waiting room)
Number of subjects: 200
Study: 18514926

Group type: EXPERIMENTAL
Intervention: AAV1/SERCA2a (MYDICAR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15964290

Group type: EXPERIMENTAL
Intervention: Misoprostol, 400 mug, given either orally or vaginally 3 h before surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 0
Study: 12693575

Group type: EXPERIMENTAL
Intervention: Mass chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clue chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screen chemotherapy
Number of subjects: 0
Study: 10091208

Group type: EXPERIMENTAL
Intervention: OAC (omeprazole 20 mg/12 h, amoxycillin 1 g/12 h, clarithromycin 500 mg/12 h)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: OCM (omeprazole 20 mg/12 h, clarithromycin 500 mg/12 h, metronidazole 500 mg/12 h)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: LAC (lansoprazole 30 mg/12 h, amoxycillin 1 g/12 h, clarithromycin 500 mg/12 h)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: LC (lansoprazole 30 mg/12 h, clarithromycin 500 mg/8 h)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Overall triple therapy
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: H. pylori eradication
Number of subjects: 111
Study: 7502549

Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (Salofalk, 4.5 g/day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: 6-methylprednisolone (Urbason, initial dose 48 mg/day, weekly tapering)
Number of subjects: 34
Study: 2258142

Group type: EXPERIMENTAL
Intervention: Recombinant alpha‐2a interferon (2.5 or 5 MU/m2)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Recombinant alpha‐2a interferon (10 MU/m2)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Patients with interferon antibodies
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Patients without interferon antibodies
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Patients with high titer neutralizing antibodies
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 54
Study: 7269436

Group type: EXPERIMENTAL
Intervention: Health resort and sanatorium treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 31883961

Group type: EXPERIMENTAL
Intervention: Solar simulated UVR or narrowband UVB (311 nm) exposure
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Skin type II
Number of subjects: 102

Group type: COMPARATOR
Intervention: Skin types II and VI comparison
Number of subjects: 102
Study: 31243733

Group type: EXPERIMENTAL
Intervention: Probiotic Bacillus cereus PAS38 (PB)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (CNTL, fed with basal diet)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Vaccine (VAC, fed with basal diet and injected with NDV vaccine)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Vaccine + Probiotic Bacillus cereus PAS38 (PBVAC)
Number of subjects: 120
Study: 29293539

Group type: EXPERIMENTAL
Intervention: Viewing a photograph of Michelle Obama's face
Number of subjects: 1223

Group type: COMPARATOR
Intervention: Control conditions (Comparison side of the porch)
Number of subjects: 1223
Study: 26488332

Group type: EXPERIMENTAL
Intervention: Continued group (mailed information regarding CRC screening choices and stool kit tests)
Number of subjects: 2208

Group type: COMPARATOR
Intervention: Stopped group (interventions were stopped)
Number of subjects: 2208
Study: 25188436

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 22616913

Group type: EXPERIMENTAL
Intervention: Exercise training programme during pregnancy (aerobic and strength exercises)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Normal care
Number of subjects: 121
Study: 20559821

Group type: EXPERIMENTAL
Intervention: Glucose (50 g)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Saccharin (placebo)
Number of subjects: 44
Study: 18614482

Group type: EXPERIMENTAL
Intervention: Replacement only when clinically indicated
Number of subjects: 755

Group type: COMPARATOR
Intervention: Routine care of catheter (control group)
Number of subjects: 755
Study: 16602471

Group type: EXPERIMENTAL
Intervention: Different antibiotics (specific types not mentioned)
Number of subjects: 100
Study: 11846850

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg, 1x daily for 3 days at week 2)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (C)
Number of subjects: 46
Study: 10576495

Group type: EXPERIMENTAL
Intervention: Triazolam
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Zopiclone
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Zolpidem
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 8880166

Group type: EXPERIMENTAL
Intervention: Stochastic cost-effectiveness analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Deterministic cost-effectiveness analysis
Number of subjects: 0
Study: 1984711

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (0.25 mg/kg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 6831292

Group type: EXPERIMENTAL
Intervention: Midazolam (0.08 mg.kg‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydroxyzine (1.5 mg.kg‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyoscine (0.4 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atropine (0.4 mg)
Number of subjects: 0
Study: 31752978

Group type: EXPERIMENTAL
Intervention: arriba-PPI tool (electronic decision support system)
Number of subjects: 3150

Group type: COMPARATOR
Intervention: Control group (usual treatment by GPs)
Number of subjects: 3150
Study: 30044486

Group type: EXPERIMENTAL
Intervention: Naloxegol 25 mg daily
Number of subjects: 1337

Group type: EXPERIMENTAL
Intervention: Naloxegol 12.5 mg daily
Number of subjects: 1337

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1337
Study: 27007995

Group type: EXPERIMENTAL
Intervention: Single-dose zonisamide at 200 mg
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Single-dose zonisamide at 300 mg
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Single-dose zonisamide at 400 mg
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Multiple-dose zonisamide at 300 mg for 14 days
Number of subjects: 39
Study: 26005127

Group type: EXPERIMENTAL
Intervention: 2 years of group music training
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1 year of music training (after a 1-year wait)
Number of subjects: 0
Study: 21722193

Group type: EXPERIMENTAL
Intervention: Overdenture supported by two implants with ball attachments (2IBA)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Overdenture supported by four implants with a triple bar (4ITB)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Overdenture supported by two implants with a bar (2ISB)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 110
Study: 20975267

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 70

Group type: COMPARATOR
Intervention: Carvedilol
Number of subjects: 70
Study: 18552624

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT) for 16 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Brief supportive psychotherapy (BSP) for 16 weeks
Number of subjects: 26
Study: 15786427

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (3 litres of polyethylene glycol)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Surgery without mechanical bowel preparation
Number of subjects: 153
Study: 11963202

Group type: EXPERIMENTAL
Intervention: Glycoprotein IIb/IIIa inhibitors administered periprocedurally
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stent placement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Protection devices
Number of subjects: 0
Study: 10357502

Group type: EXPERIMENTAL
Intervention: Coping skills intervention
Number of subjects: 132

Group type: COMPARATOR
Intervention: Peer support intervention
Number of subjects: 132

Group type: COMPARATOR
Intervention: Peer support intervention (subgroup analysis)
Number of subjects: 132
Study: 8577008

Group type: EXPERIMENTAL
Intervention: Continuous infusion (24-hour combined infusion with fat, amino acids, and glucose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sequential infusion (combined fat and amino acids during daytime and glucose alone during nighttime)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bolus infusion (nutrition provided by bolus infusions during 1 hour followed by 2 hours without any infusion)
Number of subjects: 0
Study: 1961129

Group type: EXPERIMENTAL
Intervention: Combined estrogen-progestogen therapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 6420178

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (PN)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Cyclosporine or methotrexate therapy
Number of subjects: 246

Group type: COMPARATOR
Intervention: Interferon
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Outpatient PN
Number of subjects: 246
Study: 31038621

Group type: EXPERIMENTAL
Intervention: Unsupervised group (UG) - home-based exercise protocol for 24 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (CG) - usual care
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Supervised group (SG) - supervised training for 12 weeks followed by home protocol for another 12 weeks
Number of subjects: 56
Study: 28528605

Group type: EXPERIMENTAL
Intervention: Calcipotriene 0.005% plus Betamethasone dipropionate 0.064% aerosol foam (Cal/BD)
Number of subjects: 1104

Group type: COMPARATOR
Intervention: Calcipotriene aerosol foam
Number of subjects: 1104

Group type: COMPARATOR
Intervention: Betamethasone dipropionate aerosol foam
Number of subjects: 1104

Group type: COMPARATOR
Intervention: Aerosol foam vehicle
Number of subjects: 1104

Group type: COMPARATOR
Intervention: Calcipotriene/Betamethasone dipropionate ointment
Number of subjects: 1104

Group type: COMPARATOR
Intervention: Ointment vehicle
Number of subjects: 1104
Study: 27271087

Group type: EXPERIMENTAL
Intervention: Asenapine 5 mg bid
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Asenapine 10 mg bid
Number of subjects: 532

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 532
Study: 24163439

Group type: EXPERIMENTAL
Intervention: Coping skills (TEENCOPE™)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Diabetes education (Managing Diabetes)
Number of subjects: 320
Study: 22763150

Group type: EXPERIMENTAL
Intervention: Leflunomide 100 mg/week
Number of subjects: 85

Group type: COMPARATOR
Intervention: Methotrexate 10 mg/week
Number of subjects: 85
Study: 19225065

Group type: EXPERIMENTAL
Intervention: Isocyanate exposure in asthmatic subjects
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control subjects exposed to isocyanates
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: All subjects (including controls)
Number of subjects: 42
Study: 17453978

Group type: EXPERIMENTAL
Intervention: Cardiovascular capacity, pain intensity, fear of injury/movement, cognitions, and depression
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Stair climbing
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Radiating pain, age, and duration of complaints
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 221
Study: 17535997

Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (PTx)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No Parathyroidectomy (no PTx)
Number of subjects: 50
Study: 14695845

Group type: EXPERIMENTAL
Intervention: ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stanford V (vinblastine, doxorubicin, vincristine, bleomycin, mustard, etoposide, and prednisone)
Number of subjects: 0
Study: 11040240

Group type: EXPERIMENTAL
Intervention: High-dose adrenomedullin (5.8 pmol.kg(‐1).min(‐1))
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Low-dose adrenomedullin (2.9 pmol.kg(‐1).min(‐1))
Number of subjects: 8
Study: 9083899

Group type: EXPERIMENTAL
Intervention: Local metronidazole treatment
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Systemic metronidazole treatment
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Local metronidazole combined with scaling and root planing
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Systemic metronidazole combined with scaling and root planing
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Scaling and root planing
Number of subjects: 30

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 30
Study: 8409183

Group type: EXPERIMENTAL
Intervention: nifedipine-GITS
Number of subjects: 9

Group type: COMPARATOR
Intervention: dobutamine infusion
Number of subjects: 9
Study: 3535429

Group type: EXPERIMENTAL
Intervention: Nova-T
Number of subjects: 819

Group type: COMPARATOR
Intervention: TCu200Ag
Number of subjects: 819
Study: 31960952

Group type: EXPERIMENTAL
Intervention: LBB (Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 with vitamin B6)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 31097858

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (standard protocol for 12 weeks, 3 sessions weekly for 60 minutes each)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 65
Study: 26947770

Group type: EXPERIMENTAL
Intervention: 0.6 ± 0.2 IU/kg/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1.0 ± 0.2 IU/kg/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1.4 ± 0.2 IU/kg/d
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.6 ± 0.2 IU/kg/d, 1.0 ± 0.2 IU/kg/d, 1.4 ± 0.2 IU/kg/d
Number of subjects: 60
Study: 25904424

Group type: EXPERIMENTAL
Intervention: Congenital stenosis group (n = 63)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Non-stenosis group (n = 78)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 141
Study: 22865524

Group type: EXPERIMENTAL
Intervention: Securflux®
Number of subjects: 177

Group type: COMPARATOR
Intervention: No Securflux®
Number of subjects: 177
Study: 21299290

Group type: EXPERIMENTAL
Intervention: 20-min decision aid intervention plus an information brochure
Number of subjects: 111
Study: 19430625

Group type: EXPERIMENTAL
Intervention: Ice pretreatment (cooling + topical anesthesia + counterstimulation + distraction)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Without ice pretreatment (topical anesthesia + counterstimulation + distraction)
Number of subjects: 160
Study: 16916391

Group type: EXPERIMENTAL
Intervention: Sitz baths
Number of subjects: 58

Group type: COMPARATOR
Intervention: No sitz baths
Number of subjects: 58
Study: 15498088

Group type: EXPERIMENTAL
Intervention: Glargine (once daily at dinner-time)
Number of subjects: 121

Group type: COMPARATOR
Intervention: NPH (four times/day)
Number of subjects: 121
Study: 11806071

Group type: EXPERIMENTAL
Intervention: SRP + CHX chip
Number of subjects: 484

Group type: COMPARATOR
Intervention: SRP
Number of subjects: 484
Study: 10185376

Group type: EXPERIMENTAL
Intervention: Qualitative methods in health services research
Number of subjects: 0
Study: 8066157

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 3289511

Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone (IVMP)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 31944083

Group type: EXPERIMENTAL
Intervention: Class 1 integrons detected in 67% of 100 randomly selected MDR E. coli isolates.
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: MDR E. coli isolates
Number of subjects: 198
Study: 30335180

Group type: COMPARATOR
Intervention: Health care provider advice and assistance (ARM 1)
Number of subjects: 1318

Group type: EXPERIMENTAL
Intervention: Health care provider advice and assistance plus village health worker (VHW) counseling (ARM 2)
Number of subjects: 1318
Study: 29134789

Group type: EXPERIMENTAL
Intervention: High frequency rTMS on left dorsolateral prefrontal cortex
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High frequency rTMS on right dorsolateral prefrontal cortex
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low frequency rTMS on left dorsolateral prefrontal cortex
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low frequency rTMS on right dorsolateral prefrontal cortex
Number of subjects: 50

Group type: COMPARATOR
Intervention: Active sham rTMS on P3 region
Number of subjects: 50
Study: 25286889

Group type: EXPERIMENTAL
Intervention: Cold water (10º C)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Warm water (37º C)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 10
Study: 22933433

Group type: EXPERIMENTAL
Intervention: Medium fructose (MF) at 40 g/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High fructose (HF) at 80 g/day
Number of subjects: 9

Group type: COMPARATOR
Intervention: High glucose (HG) at 80 g/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High sucrose (HS) at 80 g/day
Number of subjects: 9
Study: 21909500

Group type: EXPERIMENTAL
Intervention: Semiannual topical fluoride application (elmex fluid)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Control group (no fluoride application)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Fluoride scores (intervention)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Fluoride scores (control)
Number of subjects: 334
Study: 19426833

Group type: EXPERIMENTAL
Intervention: Zolpidem
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 16507801

Group type: EXPERIMENTAL
Intervention: G-CSF (10 microg/kg subcutaneously daily for 5 days)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 14725512

Group type: EXPERIMENTAL
Intervention: IM midazolam 0.04 mg.kg(‐1) (Group M1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: IM midazolam 0.08 mg.kg(‐1) (Group M2)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No premedication (Group C)
Number of subjects: 45
Study: 11547910

Group type: EXPERIMENTAL
Intervention: Different orienting tasks and materials in the familiarization and critical presentations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonenacted encoding during familiarization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enacted encoding during familiarization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All subjects reported experiencing source discrimination difficulties
Number of subjects: 0
Study: 9048536

Group type: EXPERIMENTAL
Intervention: Inhaled furosemide (30 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Inhaled cromolyn (30 mg)
Number of subjects: 10